Atea Pharmaceuticals Inc. (AVIR): Price and Financial Metrics
AVIR Price/Volume Stats
| Current price | $3.18 | 52-week high | $4.14 |
| Prev. close | $3.19 | 52-week low | $2.45 |
| Day low | $3.09 | Volume | 542,100 |
| Day high | $3.24 | Avg. volume | 385,020 |
| 50-day MA | $2.88 | Dividend yield | N/A |
| 200-day MA | $3.21 | Market Cap | 272.14M |
AVIR Stock Price Chart Interactive Chart >
Atea Pharmaceuticals Inc. (AVIR) Company Bio
Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.
AVIR Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
AVIR Price Returns
| 1-mo | 15.22% |
| 3-mo | 6.35% |
| 6-mo | 5.30% |
| 1-year | -14.05% |
| 3-year | -60.55% |
| 5-year | N/A |
| YTD | -5.07% |
| 2024 | 9.84% |
| 2023 | -36.59% |
| 2022 | -46.20% |
| 2021 | -78.60% |
| 2020 | N/A |